Found: 24
Select item for more details and to access through your institution.
Comparison of confidence interval methods for an intra-class correlation coefficient (ICC).
- Published in:
- BMC Medical Research Methodology, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2288-14-121
- By:
- Publication type:
- Article
Power estimation in biomarker studies where events are already observed.
- Published in:
- Clinical Trials, 2017, v. 14, n. 6, p. 621, doi. 10.1177/1740774517723830
- By:
- Publication type:
- Article
Development of omics-based clinical tests for prognosis and therapy selection: The challenge of achieving statistical robustness and clinical utility.
- Published in:
- Clinical Trials, 2013, v. 10, n. 5, p. 653, doi. 10.1177/1740774513499458
- By:
- Publication type:
- Article
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 1, p. 15, doi. 10.1007/s10549-021-06319-z
- By:
- Publication type:
- Article
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 557, doi. 10.1007/s10549-020-06030-5
- By:
- Publication type:
- Article
On the Quest of Risk Stratification in HER2-Positive Breast Cancer.
- Published in:
- 2022
- By:
- Publication type:
- editorial
An International Ki67 Reproducibility Study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 24, p. 1897, doi. 10.1093/jnci/djt306
- By:
- Publication type:
- Article
Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 22, p. 1677, doi. 10.1093/jnci/djt282
- By:
- Publication type:
- Article
Statistical Considerations in the Evaluation of Continuous Biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.251520
- By:
- Publication type:
- Article
Statistical Considerations in the Evaluation of Continuous Biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.251520
- By:
- Publication type:
- Article
Statistical Considerations in the Evaluation of Continuous Biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.251520
- By:
- Publication type:
- Article
Statistical Considerations in the Evaluation of Continuous Biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.251520
- By:
- Publication type:
- Article
Statistical Considerations in the Evaluation of Continuous Biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.251520
- By:
- Publication type:
- Article
Statistical Considerations in the Evaluation of Continuous Biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.251520
- By:
- Publication type:
- Article
Criteria for the use of omics-based predictors in clinical trials.
- Published in:
- Nature, 2013, v. 502, n. 7471, p. 317, doi. 10.1038/nature12564
- By:
- Publication type:
- Article
Two-stage adaptive cutoff design for building and validating a prognostic biomarker signature.
- Published in:
- Statistics in Medicine, 2014, v. 33, n. 29, p. 5097, doi. 10.1002/sim.6310
- By:
- Publication type:
- Article
Practical modifications to the time-to-event continual reassessment method for phase I cancer trials with fast patient accrual and late-onset toxicities.
- Published in:
- Statistics in Medicine, 2011, v. 30, n. 17, p. 2130, doi. 10.1002/sim.4255
- By:
- Publication type:
- Article
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41523-020-0147-1
- By:
- Publication type:
- Article
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.
- Published in:
- BMC Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1741-7015-11-220
- By:
- Publication type:
- Article
Impact of bevacizumab chemotherapy on craniotomy wound healing.
- Published in:
- Journal of Neurosurgery, 2011, v. 114, n. 6, p. 1609, doi. 10.3171/2010.10.JNS101042
- By:
- Publication type:
- Article
Leveraging external control data in the design and analysis of neuro-oncology trials: Pearls and perils.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 5, p. 796, doi. 10.1093/neuonc/noae005
- By:
- Publication type:
- Article
Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 11, p. 1152, doi. 10.1093/neuonc/noq075
- By:
- Publication type:
- Article
Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme†.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 9, p. 908, doi. 10.1093/neuonc/noq049
- By:
- Publication type:
- Article
Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 3, p. 274, doi. 10.1093/neuonc/nop034
- By:
- Publication type:
- Article